Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination
Abstract
: After 6 months of HAART, more than half of previously immunized children still lacked positive measles antibody. With increased use of HAART in pediatric populations, revaccination against measles and tetanus should be considered to boost response rates and immunization coverage.
Keywords
immunization
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
statistical
research support
female
male
N.I.H.
Extramural
Child
preschool
Antibodies
hiv-1*
Cohort Studies
anti-hiv agents / therapeutic use
kenya
immunoglobulin g / blood
data interpretation
bacterial / blood
antiretroviral therapy
hiv infections / immunology*
measles vaccine / immunology*
highly active*
hiv infections / drug therapy*
tetanus toxoid / immunology*
measles vaccine / administration & dosage
tetanus toxoid / administration & dosage
pmid:19258919
pmc2779204
doi:10.1097/inf.0b013e3181903ed3
carey farquhar
dalton wamalwa
barbara lohman-payne
secondary
Citation
ID:
117158
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
117158
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
